Kato K, Ito H, Inaguma Y, Okamoto K, Saga S
Department of Biochemistry, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Aichi 480-03, Japan.
J Biol Chem. 1996 Oct 25;271(43):26989-94. doi: 10.1074/jbc.271.43.26989.
When C6 cells in culture were exposed at 37 degrees C to 1 microM colchicine or to 1 microM colcemid, a tubulin-binding antimitotic alkaloid, levels of alphaB crystallin in cells began to increase after about 10 h, reaching a maximum of more than 1 microg/mg protein after 24 h. The level of alphaB crystallin returned to near the control level within two subsequent days of culture in the normal medium. Northern blot analysis showed that the accumulation of alphaB crystallin was preceded by an increase in the level of the mRNA for alphaB crystallin. Nuclear run-off transcription assays showed that colchicine induced new synthesis of mRNA for alphaB crystallin. Immunofluorescence staining revealed that alphaB crystallin accumulated in the peripheral areas of cells, as did the depolymerized tubulin, after several hours of treatment with colcemid, and then it gradually became more conspicuous in the cytoplasm. Vinblastine and nocodazole, which also promote the disassembly of microtubules by binding to tubulins, also induced the synthesis of alphaB crystallin. Furthermore, induction of alphaB crystallin by these drugs was observed in quiescent cells that had been cultured in serum-free medium. However, taxol, a microtubule-stabilizing antimitotic agent, did not stimulate the synthesis of alphaB crystallin, but rather, it suppressed the induction of synthesis of alphaB crystallin by the microtubule-disrupting drugs. Induction of alphaB crystallin by colchicine or by other drugs that promote the disassembly of microtubules was sensitive to staurosporine, an inhibitor of protein kinases, and the induction was completely suppressed in the presence of 10 nM staurosporine. These results suggest that the expression of alphaB crystallin is stimulated, via phosphorylation reactions that are sensitive to staurosporine, when the depolymerization of microtubules is enhanced.
当培养的C6细胞在37℃下暴露于1微摩尔秋水仙碱或1微摩尔秋水仙酰胺(一种与微管蛋白结合的抗有丝分裂生物碱)时,细胞中αB晶状体蛋白的水平在约10小时后开始增加,24小时后达到最高值,超过1微克/毫克蛋白质。在随后正常培养基培养的两天内,αB晶状体蛋白水平恢复到接近对照水平。Northern印迹分析表明,αB晶状体蛋白的积累之前是αB晶状体蛋白mRNA水平的增加。核转录分析表明,秋水仙碱诱导了αB晶状体蛋白mRNA的新合成。免疫荧光染色显示,在用秋水仙酰胺处理数小时后,αB晶状体蛋白在细胞周边区域积累,解聚的微管蛋白也是如此,然后它在细胞质中逐渐变得更加明显。长春碱和诺考达唑也通过与微管蛋白结合促进微管的解聚,它们也诱导了αB晶状体蛋白的合成。此外,在无血清培养基中培养的静止细胞中也观察到这些药物对αB晶状体蛋白的诱导作用。然而,紫杉醇是一种稳定微管的抗有丝分裂剂,它不会刺激αB晶状体蛋白的合成,反而会抑制微管破坏药物对αB晶状体蛋白合成的诱导作用。秋水仙碱或其他促进微管解聚的药物对αB晶状体蛋白的诱导作用对蛋白激酶抑制剂星形孢菌素敏感,在存在10纳摩尔星形孢菌素的情况下,诱导作用被完全抑制。这些结果表明,当微管解聚增强时,αB晶状体蛋白的表达通过对星形孢菌素敏感的磷酸化反应受到刺激。